MDCE Adds Q3 2026 Financials and Going-Concern Warning to $325,798 Reg A Offering
MDCE filed a Financing and Capital Events on light trading volume (0.1× avg).
Summary
Medical Care Technologies amended its Reg A offering circular to add September 30, 2026 financials and a going-concern warning, while keeping the $0.00012 per-share price for up to 2,714,987,988 shares ($325,798 maximum).
Key Events · Financing and Capital Events · MDCE
-
Reg A Terms Unchanged at $0.00012
The amendment keeps the offering at up to 2,714,987,988 common shares at $0.00012 per share for a $325,798 maximum, with 1,402,736,772 shares already sold at $0.00006.
-
Going-Concern Warning Disclosed
The filing states an accumulated deficit of $10,423,441 as of September 30, 2026 and that these factors raise substantial doubt about the Company's ability to continue as a going concern.
-
Q3 2026 Net Income of $192,565
Three months ended September 30, 2026 revenue was $538,981 with gross profit of $240,839 and net income of $192,565, versus $52,103 net income a year earlier.
-
Share Count Rises to 4.95 Billion
Common shares outstanding reached 4,945,012,002 at September 30, 2026 from 3,250,167,248 at December 31, 2025, after 1,402,736,772 Reg A shares were issued in Q3 2026 for $84,164 gross proceeds.
Analysis · MDCE · Trade & Services
The Reg A offering still stands at $0.00012 per share for up to 2,714,987,988 shares ($325,798 maximum), but this post-qualification amendment now carries September 30, 2026 financials and an explicit going-concern statement tied to a $10,423,441 accumulated deficit. Operating results are improving: Q3 2026 revenue of $538,981 produced $192,565 of net income. Even so, the company says substantial doubt exists about its ability to continue. For holders, the dilution is severe. Already, 1,402,736,772 shares were sold at $0.00006 for $84,164, and the remaining 2,714,987,988 shares at $0.00012 would take the count from 5,265,012,002 to 7,979,999,990. The $0.00012 offering price is above the $0.0001 closing price on October 28, 2026 stated in the filing, but the penny-stock price and the going-concern language mean the capital raise is about survival, not growth.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MDCE was trading at $0.00 on OTC in the Trade & Services sector, with a market capitalization of approximately $331.6K. The 52-week trading range was $0.00 to $0.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.